Our Product

About Coxor™

Coxor™ 300mg Acetylsalisylic acid

Coxor™ is a powder and solvent for oral solution for emergency treatment for suspected acute myocardial infarction. This medicine is used in adults above 18 years for suspected acute myocardial infarction (heart attack) after contact with emergency medical services.

In case of symptoms of a suspected acute myocardial infarction, the patient should call the national rescue number as soon as possible. If advised to do so by the emergency medical services, 300 mg of Coxor™ should be taken as quickly as possible.

The content is to be drunken following reconstitution. The powder is to be dissolved in the solvent and shaken until it is dissolved.

Please read the information on the Coxor package and the summary of product characteristics carefully.

Production
Asamedic started production of the drug in the fall of 2018 and set 6,000 vials in stability program. Full scale production started november 2020.
DCP
DCP well-established use application was submitted in December 2019, with Norway as RMS and Denmark as CMS.
Positive outcome
End of procedure with a positive outcome took place in January 2021.